We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDAY
801
USA Today Co
TDAY
$1.29B
$363K ﹤0.01%
210,938
+62,391
+42% +$146K
WBS icon
802
Webster Financial
WBS
$12.3B
$356K ﹤0.01%
9,802
-2,057
-17% -$98.7K
GNRC icon
803
Generac Holdings
GNRC
$11.5B
$355K ﹤0.01%
3,569
-4,910
-58% -$568K
DSGX icon
804
Descartes Systems
DSGX
$6.68B
$354K ﹤0.01%
+4,778
New +$356K
COIN icon
805
Coinbase
COIN
$42.2B
$351K ﹤0.01%
+5,639
New +$338K
SEIC icon
806
SEI Investments
SEIC
$12.3B
$344K ﹤0.01%
+6,495
New +$389K
MHK icon
807
Mohawk Industries
MHK
$6.91B
$343K ﹤0.01%
+3,713
New +$405K
ADV icon
808
Advantage Solutions
ADV
$575M
$340K ﹤0.01%
9,360
+2,391
+34% +$135K
VERV
809
DELISTED
Verve Therapeutics
VERV
$339K ﹤0.01%
+25,547
New +$500K
ALLK
810
DELISTED
Allakos
ALLK
$337K ﹤0.01%
82,313
-35,135
-30% -$225K
SGMO
811
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$328K ﹤0.01%
+202,674
New +$578K
BP icon
812
BP
BP
$112B
$328K ﹤0.01%
+64
New +$2.39K
CG icon
813
Carlyle Group
CG
$16.1B
$322K ﹤0.01%
+11,265
New +$376K
PVLA
814
Palvella Therapeutics
PVLA
$2.05B
$316K ﹤0.01%
4,398
-7,375
-63% -$854K
FSV icon
815
FirstService
FSV
$6.55B
$313K ﹤0.01%
2,415
AQN icon
816
Algonquin Power & Utilities
AQN
$4.59B
$303K ﹤0.01%
39,348
-11,364
-22% -$85.5K
RTX icon
817
RTX Corp
RTX
$290B
$294K ﹤0.01%
+3,265
New +$322K
INO icon
818
Inovio Pharmaceuticals
INO
$85.6M
$287K ﹤0.01%
+31,668
New +$540K
IP icon
819
International Paper
IP
$22.6B
$282K ﹤0.01%
8,489
+1,004
+13% +$37.2K
CVE icon
820
Cenovus Energy
CVE
$54.2B
$281K ﹤0.01%
17,512
+2,428
+16% +$44.6K
SWTX
821
DELISTED
SpringWorks Therapeutics
SWTX
$272K ﹤0.01%
11,490
-150,619
-93% -$4.4M
FULC icon
822
Fulcrum Therapeutics
FULC
$241M
$266K ﹤0.01%
+101,337
New +$908K
MPT
823
Medical Properties Trust
MPT
$2.84B
$255K ﹤0.01%
33,685
-6,713
-17% -$74.1K
WFC icon
824
Wells Fargo
WFC
$254B
$246K ﹤0.01%
7,157
-253,298
-97% -$11M
NHI icon
825
National Health Investors
NHI
$3.79B
$237K ﹤0.01%
5,000

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.